Methadone for 'Adenocarcinopathic' Pain Treatment

Clinical trial NCT05325164 · WITHDRAWN

Trial details

NCT number: NCT05325164
Sponsor: Ottawa Hospital Research Institute
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Pain Adenocarcinoma

Start date: 2022-09-01
Primary completion: 2023-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.